GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Actinium Pharmaceuticals ATNM · USD

Health Care · US listing · 🇺🇸 United States

Compare

1.54

+7.69%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Actinium Pharmaceuticals

From its filings with the US Securities and Exchange Commission

SEC filings

Actinium Pharmaceuticals is based in New York, New York and is incorporated in Delaware. Its shares trade on NYSE under the ticker ATNM. The SEC classifies its business as pharmaceutical preparations. In the fiscal year to 31 December 2025, it reported revenue of $90,000 and a net loss of $33.9m. At that date it held total assets of $51.8m and shareholders' equity of $7.8m.

Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Biotechnology
Listed since
26 Mar 2014
Employees
25
Head office
100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
Incorporated in
DE
Classification
Pharmaceutical Preparations
Filer status
Non-accelerated filer<br>Smaller reporting company

Leadership

Pay as last reported

  • Mr. Sandesh SethChairman of the Board, Chief Executive Officer, since 2012$4.7m
  • Mr. Steve O'LoughlinChief Financial Officer, Corporate Secretary$1.5m
  • Dr. June AlmenoffIndependent Director
  • Dr. Jeffrey ChellIndependent Director$300,997
  • Dr. C. David NicholsonLead Independent Director$312,997
  • Dr. Ajit ShettyIndependent Director$308,497
  • Mr. Richard SteinhartIndependent Director$312,997

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
15
Environment
14
Social
26
Governance
6
Carbon reduction policy
No
Human rights policy
No

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.